NCT02063516

Brief Summary

To compare insertion characteristics of 2 different supraglottic devices (Guardian LMA and Proseal LMA) and to observe any associated complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 13, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 14, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
2 months until next milestone

Results Posted

Study results publicly available

December 18, 2014

Completed
Last Updated

January 26, 2015

Status Verified

December 1, 2014

Enrollment Period

1.2 years

First QC Date

January 13, 2014

Results QC Date

December 10, 2014

Last Update Submit

January 10, 2015

Conditions

Keywords

Airway CuffGuardianProsealCuff Pressurelaryngeal Mask Airway

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal Seal Pressure

    This will be measured over the full range of cuff volumes (0-40 ml) and at an intracuff pressure of 60 cm H2O.

    5 min

Secondary Outcomes (1)

  • Anatomic Position

    5 min

Other Outcomes (1)

  • Amount of Air Added to Keep Cuff Pressure 60cmH20.

    30 minutes, 60 minutes, 90 minutes and 120 minutes

Study Arms (2)

Guardian

EXPERIMENTAL

Device: Guardian Laryngeal Mask

Device: Guardian Laryngeal Mask

Proseal

EXPERIMENTAL

Device:Proseal Laryngeal Mask Airway

Device: Proseal Laryngeal Mask Airway

Interventions

Guardian Laryngeal Mask: The Guardian Laryngeal Mask (Ultimate Medical Pty Ltd, Richmond, Vic, Australia) is a new silicone-based single-use extraglottic airway device that forms a seal with the glottis for ventilation and with the hypopharynx for airway protection, and provides a gastric drainage port. In addition, it has a port for suctioning material from the hypopharynx and a pilot balloon valve that constantly monitors intracuff pressure. In the following randomized, non-crossover study, the investigators test if oropharyngeal leak pressures differed between the Guardian Laryngeal Mask and the LMA proseal in paralysed, anaesthetised patients.

Guardian

Proseal Laryngeal Mask Airway: Silicon based, reusable, modified dorsal cuff and drainage tube

Proseal

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 65 years of age
  • Mallampati score less than 3
  • thyromental distance more than 6.5 cm
  • mouth opening more than \>2.5 cm
  • a body mass index less than 35 kg/m2;

You may not qualify if:

  • Body weight 50 Kg
  • Pregnancy
  • Difficult airway
  • Recent history of upper respiratory tract infection and sore throats
  • A history of esophageal reflux disease
  • ENT surgery
  • Laparoscopic surgery
  • Inability to understand the Study Information Sheet and provide a written consent to take part in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, 300052, China

Location

Related Publications (1)

  • Pajiyar AK, Wen Z, Wang H, Ma L, Miao L, Wang G. Comparisons of clinical performance of Guardian laryngeal mask with laryngeal mask airway ProSeal. BMC Anesthesiol. 2015 May 1;15:69. doi: 10.1186/s12871-015-0039-3.

Limitations and Caveats

We only use size-4 devices in adult patients with neuromuscular blockade, we presumed that same results would be obtained in patients who have not received neuromuscular blockade. lastly our data was not blinded causing potential source of bias.

Results Point of Contact

Title
Dr. Haiyun Wang
Organization
tianjinMUGH

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-Professor

Study Record Dates

First Submitted

January 13, 2014

First Posted

February 14, 2014

Study Start

June 1, 2013

Primary Completion

August 1, 2014

Study Completion

November 1, 2014

Last Updated

January 26, 2015

Results First Posted

December 18, 2014

Record last verified: 2014-12

Locations